Lupin surges to 52-week high on receiving US FDA clearance byprema •October 01, 2023 Lupin US FDA clearance in lupin pharma Lupin's shares saw a substantial increase of about 4 percent, reaching a 52-week high at Rs 1,184.70 on September 29. This surge was prompted by the US Food and Drugs Administration (FDA) issuing an Estab…
